1-(3-Methyl-4-nitrophenyl)piperidine

Catalog No.: 
ACFNVQ947
CAS No.: 
120534-11-4
Molecular Formula: 
C12H16N2O2
Molecular Weight: 
220.27
1-(3-Methyl-4-nitrophenyl)piperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$81.00InquiryInquiry
1g95%$140.00InquiryInquiry
5g95%$427.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Methyl-4-nitrophenyl)piperidine
IUPAC Name1-(3-methyl-4-nitrophenyl)piperidine
MDL No.MFCD01414802
Molecular FormulaC12H16N2O2
Molecular Weight220.27
SMILESO=[N+](C1=CC=C(N2CCCCC2)C=C1C)[O-]
InChI KeyZOZCXFUMHHBNRH-UHFFFAOYSA-N
Synonym1-(3-methyl-4-nitrophenyl)piperidine;Piperidine, 1-(3-methyl-4-nitrophenyl)-
CAS No.120534-11-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFNVQ947 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTEPI768 route compound structure diagram
    ACTEPI768446-33-3In Stock
  4. Then
  5. ACFNVQ947 route product structure diagram
    ACFNVQ947120534-11-4
Inquiry

2. ACFNVQ947 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJYBI092 route compound structure diagram
    ACJYBI0925367-28-2In Stock
  4. Then
  5. ACFNVQ947 route product structure diagram
    ACFNVQ947120534-11-4
Inquiry

3. ACFNVQ947 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKZUQ682 route compound structure diagram
    ACKZUQ68252414-98-9In Stock
  4. Then
  5. ACFNVQ947 route product structure diagram
    ACFNVQ947120534-11-4
Inquiry

Comments (0)